C07D 473/10
With methyl radicals in positions 3 and 7
Official title: with methyl radicals in positions 3 and 7, e.g. theobromine
C07D473/10 (With methyl radicals in positions 3 and 7) appears on 90 US grants and 45 published applications in this corpus.
Search patents in C07D- Granted patents
- 90
- Published applications
- 45
- Assignees
- 48
- Inventors
- 208
- Latest grant
- 3 Jun 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 2 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 4 | 0 |
| 1985 | 5 | 0 |
| 1986 | 4 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 3 | 0 |
| 1990 | 3 | 0 |
| 1991 | 2 | 0 |
| 1992 | 2 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 4 | 0 |
| 1996 | 4 | 0 |
| 1997 | 9 | 0 |
| 1998 | 11 | 0 |
| 1999 | 3 | 0 |
| 2000 | 4 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 2 |
| 2003 | 1 | 0 |
| 2004 | 2 | 3 |
| 2005 | 1 | 1 |
| 2006 | 1 | 3 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 2 |
| 2010 | 0 | 3 |
| 2011 | 1 | 3 |
| 2012 | 1 | 4 |
| 2013 | 0 | 3 |
| 2014 | 0 | 5 |
| 2015 | 3 | 4 |
| 2016 | 2 | 0 |
| 2017 | 1 | 1 |
| 2018 | 0 | 3 |
| 2019 | 1 | 0 |
| 2020 | 2 | 2 |
| 2021 | 1 | 1 |
| 2022 | 1 | 1 |
| 2023 | 0 | 0 |
| 2024 | 1 | 0 |
| 2025 | 1 | 0 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Composition and method for culturing organoids3 Jun 2025US 12,319,937 B2Organoidsciences Ltd.
- Compositions for treatment of inflammation23 Jan 2024US 11,878,994 B1Metro International Biotech, LLC
- Pharmaceutical salts/co-crystals of pentoxifylline, clonidine and linsidomine with caffeic, protocatechuic or alpha-lipoic acid an use thereof for treatment of pain29 Nov 2022US 11,510,926 B2The Royal Institution for the Advancement of Learning/Mcgill University
- Method for preparation of alkylated or fluoro, chloro and fluorochloro alkylated compounds by heterogeneous cobalt catalysis6 Apr 2021US 10,968,187 B2Lonza Solutions AG
- Anti-ice nucleation activator28 Apr 2020US 10,633,570 B2Shin Nippon Yakugyo Co., Ltd.
- Crystalline complexes between velagliflozin and selected co-crystal forming agents, methods for their preparation and the use thereof for preparing medicaments24 Sep 2026US 2026/0285825 A1Boehringer Ingelheim Vetmedica GmbH
- Nucleoside derivative for preventing and treating inflammation and application thereof26 Mar 2026US 2026/0083743 A1West China Hospital, Sichuan University
- Novel cocrystals of methylxanthines, their polymorphs and process thereof5 Mar 2026US 2026/0062414 A1Fertis India Pvt Ltd
- Nucleoside derivative for preventing and treating inflammation and application thereof15 Sep 2022US 2022/0288084 A1West China Hospital, Sichuan University
- Pharmaceutical salts/co-crystals of pentoxifylline, clonidine and linsidomine with caffeic, protocatechuic or alpha-lipoic acid an use thereof for treatment of pain15 Jul 2021US 2021/0213025 A1The Royal Institution for the Advancement of Learning/Mcgill University
Most cited
By later US patents
- Compounds for inhibition of ceramide-mediated signal transduction117US 6,323,201 B1The Regents of the University of California · 2001
- Compounds for inhibition of ceramide-mediated signal transduction96US 6,562,819 B2The Regents of the University of California · 2003
- Antimigraine 8-[3-(4-aminocarbonyl piperazino and piperidino) propyl[xanthines93US 4,599,338 AAdir, S.A.R.L. · 1986
- Pharmaceutical compositions54US 4,515,795 AHoechst Aktiengesellschaft · 1985
- Cell signaling inhibitors51US 5,470,878 ACell Therapeutics, Inc. · 1995